African horsesickness virus serotype 4 (AHSV-4) outer-capsid proteins VP2 or VP2 and VP5, prepared from single or dual recombinant baculovirus expression vectors grown in Sf9 insect cells, were administered in different amounts to horses and the neutralizing antibody responses were measured. Control and vaccinated horses were challenged with virulent AHSV-4 6 months later and monitored post challenge. The results indicated that two inoculations of extracts containing VP2 and VP5, or VP2 alone, in doses of 5 µg VP2 or more per horse, were sufficient to elicit protection against African horsesickness (AHS) disease. The recombinant VP2 protein is a potential candidate vaccine for AHS in horses.
BradfordM.1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
BurrageT. G.,
TrevejoR.,
Stone-MarschatM.,
LaegreidW. W.1993; Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2. Virology 196:799–803
HowellP. G.1962; The isolation and identification of further antigenic types of African horsesickness virus. Onderstepoort Journal of Veterinary Research 29:139–149
HuismansH.,
Van Der WaltN. T.,
CloeteM.,
ErasmusB. J.1987; Isolation of capsid protein of bluetongue that induces a protective immune response in sheep. Virology 157:172–179
Martinez-TorrecuadradaJ. L.,
IwataH.,
VenteoA.,
CasalI.,
RoyP.1994; Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization. Virology 202:348–359
MertensP. P. C.1994; Orbiviruses and Coltiviruses. In Encyclopedia of Virology vol 2 pp 941–956 Edited by
WebsterR. G.,
GranoffA.
San Diego: Academic Press;
ReidR.,
van der MeydenC. H.,
ErasmusB. J.,
MeyerH.,
HamiltonA. M.1992; Encephalitis and chorioretinitis associated with neurotropic African horsesickness virus infection in laboratory workers. Part II. Ophthalmological findings. South African Medical Journal 81:454–459
RoyP.,
BishopD. H. L.,
LeBloisH.,
ErasmusB. J.1994b; Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 12:805–811
TaylorM. B.,
Van Der MeydenC. H.,
ErasmusB. J.,
ReidR.,
LabuscagneJ. H.,
DreyerL.,
ProzeskyO. W.1992; Encephalitis and chorioretinitis associated with neurotropic African horsesickness virus infection in laboratory workers. Part IV. Experimental infection of the vervet monkey (Cercopithecus pygerythrus). South African Medical Journal 81:462–467
Van Der MeydenC. H.,
ErasmusB. J.,
SwanepoelR.,
ProzeskyO. W.1992; Encephalitis and chorioretinitis associated with neurotropic African horsesickness virus infection in laboratory workers. Part I. Clinical and neurological observations. South African Medical Journal 81:451–454